NDC 0264-1943

Hyperlyte CR

Multi Electrolyte Concentrate

Hyperlyte CR is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Potassium Acetate; Sodium Chloride; Sodium Acetate; Magnesium Chloride; Calcium Chloride.

• Product ID: 0264-1943_04fffe7e-5bee-4824-a5e4-b1f8b8d1f811
• NDC: 0264-1943
• Product Type: Human Prescription Drug
• Proprietary Name: Hyperlyte CR
• Generic Name: Multi Electrolyte Concentrate
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2012-04-12
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: B. Braun Medical Inc.
• Substance Name: POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM ACETATE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE
• Active Ingredient Strength: 2 g/20mL; g/20mL; g/20mL; g/20mL; g/20mL
• Pharm Classes: Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0264-1943-20

12 CONTAINER in 1 CASE (0264-1943-20) > 250 mL in 1 CONTAINER

• Marketing Start Date: 2012-04-12
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0264-1943-20 [00264194320]

Hyperlyte CR INJECTION, SOLUTION, CONCENTRATE

• Marketing Category: UNAPPROVED DRUG OTHER
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2012-04-12

Drug Details

Active Ingredients

Ingredient	Strength
POTASSIUM ACETATE	1.96 g/20mL

OpenFDA Data

• SPL SET ID: beb5b6e0-46ed-443d-aad9-eebe389b7672
• Manufacturer:
  • B. Braun Medical Inc.
• UNII:
  • M911911U02
  • M4I0D6VV5M
  • 02F3473H9O
  • 4550K0SC9B
  • 451W47IQ8X

Pharmacological Class

• Calculi Dissolution Agent [EPC]
• Magnesium Ion Exchange Activity [MoA]
• Osmotic Laxative [EPC]
• Osmotic Activity [MoA]
• Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
• Increased Large Intestinal Motility [PE]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Blood Coagulation Factor [EPC]
• Increased Coagulation Factor Activity [PE]
• Calcium [CS]
• Cations
• Divalent [CS]
• Potassium Compounds [CS]
• Potassium Salt [EPC]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]